Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
08 September 2025 | Story Anthony Mthembu | Photo Lunga Luthuli
Martin Nyaka
Martin Nyaka, Second Deputy Secretary General of the South African Union of Students (SAUS).

Martin Nyaka, Secretary General of the 2024-2025 Institutional Student Representative Council (ISRC) and Policy and Transformation Officer (CSRC) on the Bloemfontein Campus of the University of the Free State (UFS), has been elected as Second Deputy Secretary General (DSG) of the South African Union of Students (SAUS)

Nyaka was elected during the first leg of the SAUS conference, held in Gqeberha from 10-13 July 2025. His election is historic, as this is the first time the union has appointed a second DSG. In his new role, he joins the National Executive Council (NEC) alongside the SAUS President, Deputy President, Secretary General, Treasurer-General, and the First DSG.  

“It is a great honour for me to have represented the University of the Free State at this important platform, and I remain deeply grateful for the support and assistance I received from the institution throughout this journey,” said Nyaka. He will serve in this role until the next election in 2028. 

 

Anticipated impact

Nyaka explained that his decision to stand for election was influenced by challenges he and his SRC colleagues encountered when addressing certain student-related issues. He noted that some concerns, such as those linked with the National Student Financial Aid Scheme (NSFAS), can only be resolved at a national level. 

“This position places us in a better position to assist students and to ensure that our students are funded,” he said.  

In addition to his role as Second DSG, Nyaka also chairs the SAUS Monitoring and Evaluation portfolio, which oversees several sub-committees within the organisation.  

 

Lessons from leadership 

As his SRC term draws to a close, Nyaka reflected on the lessons he will carry into this new role. 

“Previously, as student leaders our mindset was very radical, and if ever things would not go our way, we would take to the streets,” he explained. “However, over this last term, the SRC resolved matters and reached agreements with management without protest. An important lesson I take with me is that radicalism is not always the answer. In an organisation like SAUS, we need to sit down and have discussions with stakeholders when there is a deadlock.”

Nyaka emphasised that what excites him most about the opportunity is the chance to work alongside student-leaders from across the country who are equally committed to making a meaningful impact.  

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept